Elevance Health, Inc. (ELV) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and gover...
Elevance Health, Inc.'s revenue increased 12.5% year over year, from $177.01B to $199.13B.
Net income decreased 5.3% over the same period, from $5.98B to $5.66B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 135% in total.
Total debt remained relatively stable at $30.95B.
The debt-to-equity ratio stands at 0.71, indicating a moderate leverage profile.
Operating cash flow declined 26.1% to $4.29B.
Elevance Health, Inc. maintains a moderate net profit margin of 2.8%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $45.11B+2.8% | $1.02B | $40.01B | $1.37B | $2.68B | $116.53B | $25.05B | $43.77B |
| Q4 FY2024 | $45.44B+0.7% | $418.0M | $39.43B | $606.0M | $706.0M | $116.89B | $29.58B | $41.31B |
| Q1 FY2025 | $48.89B+7.6% | $2.18B | $43.91B | $2.80B | $1.02B | $119.72B | $28.36B | $42.50B |
| Q2 FY2025 | $49.78B+1.8% | $1.74B | $44.48B | $2.29B | $2.05B | $121.94B | $28.54B | $43.72B |
| Q3 FY2025 | $50.71B+1.9% | $1.19B | $45.33B | $1.41B | $1.14B | $122.75B | $31.35B | $43.95B |
| Q4 FY2025 | $49.75B-1.9% | $547.0M | $44.23B | $215.0M | $84.0M | $121.49B | $30.95B | $43.88B |
| Q1 FY2026 | $50.18B+0.9% | $1.76B | $44.72B | $2.30B | $4.33B | N/A | N/A | N/A |
| Q2 FY2026 | $50.47B+0.6% | $1.46B | $44.98B | $2.66B | $1.91B | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
Elevance Health, Inc. (ELV) Financial Statements & Revenue History
Elevance Health, Inc. (ELV) is a US-listed stock operating in the Healthcare sector, specifically the Healthcare Plans industry trading at $426.44 with a market capitalization of $92. This page provides 41 historical financial statements for Elevance Health, Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Elevance Health, Inc. reported revenue of $199.1 billion, representing 12.5% year-over-year growth. The net profit margin of 2.8% suggests thin margins. The debt-to-equity ratio of 0.71 reflects moderate leverage.
ELV Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Elevance Health, Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether ELV is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track ELV's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Elevance Health, Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of ELV's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use ELV Financial Data
Investors use Elevance Health, Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare ELV's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how ELV's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View ELV's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Elevance Health, Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.ELV trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.